Fibrinogen and Antifibrinolytic Proteins: Interactions and Future Therapeutics

Thrombus formation remains a major cause of morbidity and mortality worldwide. Current antiplatelet and anticoagulant therapies have been effective at reducing vascular events, but at the expense of increased bleeding risk. Targeting proteins that interact with fibrinogen and which are involved in h...

Descripción completa

Detalles Bibliográficos
Autores principales: Pechlivani, Nikoletta, Kearney, Katherine J., Ajjan, Ramzi A.
Formato: Online Artículo Texto
Lenguaje:English
Publicado: MDPI 2021
Materias:
Review
Acceso en línea:https://www.ncbi.nlm.nih.gov/pmc/articles/PMC8625824/
https://www.ncbi.nlm.nih.gov/pubmed/34830419
http://dx.doi.org/10.3390/ijms222212537

Internet

https://www.ncbi.nlm.nih.gov/pmc/articles/PMC8625824/
https://www.ncbi.nlm.nih.gov/pubmed/34830419
http://dx.doi.org/10.3390/ijms222212537

Ejemplares similares